<DOC>
	<DOCNO>NCT00260026</DOCNO>
	<brief_summary>Researchers Memorial Sloan-Kettering Cancer Center conduct research study Chinese herbal medicine know `` Jin Fu Kang '' . We want see help patient advanced lung cancer . Jin Fu Kang might reduce growth cancer improve quality life . You eligible trial cancer progress prior chemotherapy doctor recommend chemotherapy treatment . Lung cancer confirm spread call advanced cancer . There know permanent cure advance lung cancer , chemotherapy may temporarily shrink cancer improve quality patient ' life .</brief_summary>
	<brief_title>Safety Pharmacokinetics Jin Fu Kang Comb w/Docetaxel Patients w/Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Jin Fu Kang herbal medicine specially developed China treatment lung cancer . It base traditional medicine widely use appear safe . Although clinical trial China suggest Jin Fu Kang may benefit , never research patient lung cancer United States . As , risk benefit fully understood . The scientific aim determine toxicity Jin Fu Kang/docetaxel combination treatment patient non-small cell lung cancer , determine whether Jin Fu Kang alters pharmacokinetics docetaxel provide preliminary efficacy survival data Jin Fu Kang/docetaxel combination treatment patient non-small cell lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Patients must meet follow inclusion criterion : Pathologic confirmation stage III IV NSCLC . Docetaxel therapy cancer clinically indicate . KPS &gt; =60 % *ANC &lt; 1,000/mcl Platelets &lt; 100/mcl Patients must meet none follow exclusion criterion : WBC &lt; 4,000/µl , hemoglobin &lt; 10 g/dl , platelet count &lt; 100,000/µl , total bilirubin &gt; ULN , AST &gt; 1.5 x ULN , alkaline phosphatase &gt; 2.5 x ULN , creatinine &gt; 1.5 mg/dl creatinine clearance &lt; 50 ml/min/1.7 m2 ) , ( ANC &gt; 10,000/µl ) Prior docetaxel Patient must recover previous treatmentrelated toxicity Concurrent use botanical anticancer intent Use Jin Fu Kang constituent botanical previous three week . History allergy constituent botanical Jin Fu Kang . Pregnant lactate woman woman childbearing potential use effective contraception . A negative pregnancy test must document screening period woman childbearing potential . Concurrent active cancer . Concurrent use immunosuppressive : immunostimulant , astragaluscontaining product contraindicate patient immunosuppressive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Lung Cancer</keyword>
</DOC>